Breast cancer drug combination could stop cancer “in its tracks”

[News]

The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer “in its tracks”.

More... (http://www.news-medical.net/news/20110926/Breast-cancer-drug-combination-could-stop-cancer-e2809cin-its-trackse2809d.aspx)